Medicus Pharma
MDCX----
Medicus Pharma (MDCX)
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is deve...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Medicus Pharma Analyst Rating
View MoreForecast & Rating
Jun 15, 2026Price forecast
$5.671680.85%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- StockTitan · 15 hours ago
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome | MDCX Stock News
- PUBT · Jul 16 at 06:30 AM
Medicus Pharma wins FDA backing for optimized Phase 2 Teverelix study in acute urinary retention
- benzinga_article · Jul 13 at 04:05 PM
12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga_article · Jun 22 at 07:00 AM
Medicus Pharma To Highlight SkinJect Phase 2 Data And Teverelix Clinical Advances At BIO 2026
- StockTitan · Jun 21 at 10:30 PM
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 | MDCX Stock News
- Price Alert · Jun 21 at 07:56 PM
U.S. stock night market fluctuations: MDCX rose 12.63% in night trading with no positive news, increased volatility awaits resolution
